This is a single-centre observational study. All participants will be recruited from the Emergency Department at the Royal Infirmary of Edinburgh and invited for an outpatient CTCA at the Clinical Research Imaging Centre. This study will inform Dr. Lee’s PhD funded as part of a British heart Foundation Fellowship.
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.